Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sugama Chicklore

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2025
The utility of [<sup>18</sup>F]FDG PET in discriminating between local recurrence and inflammatory changes following SABR in primary lung cancer patientsMaria Fala, Eleni Josephides, Sweni Shah, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2019
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatmentKaren D Bosch, Sugama Chicklore, Gary J Cook, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2012
Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?Gary J R Cook, Connie Yip, Muhammad Siddique, et al.
Nuclear Medicine Communications|October 30, 2023
BNMS UK PET standardsGary J R Cook, John Dickson, Sugama Chicklore, et al.
Radiology|April 22, 2015
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and PrognosisGary J R Cook, Mary E O'Brien, Muhammad Siddique, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast CancerMelek Akay, Jennifer Glendenning, Holly Tovey, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2025
The utility of [<sup>18</sup>F]FDG PET in discriminating between local recurrence and inflammatory changes following SABR in primary lung cancer patientsMaria Fala, Eleni Josephides, Sweni Shah, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2019
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatmentKaren D Bosch, Sugama Chicklore, Gary J Cook, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2012
Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?Gary J R Cook, Connie Yip, Muhammad Siddique, et al.
Nuclear Medicine Communications|October 30, 2023
BNMS UK PET standardsGary J R Cook, John Dickson, Sugama Chicklore, et al.
Radiology|April 22, 2015
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and PrognosisGary J R Cook, Mary E O'Brien, Muhammad Siddique, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast CancerMelek Akay, Jennifer Glendenning, Holly Tovey, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Pageof 2